Russo N, Shapiro R, Vallee B L
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Biochem Biophys Res Commun. 1997 Feb 24;231(3):671-4. doi: 10.1006/bbrc.1997.6167.
As a first step toward the development of stable, selective, and potent inhibitors of those members of the pancreatic RNase superfamily that induce biological responses, we have focussed on low molecular weight compounds and studied their interactions with the active-site of bovine pancreatic ribonuclease A (RNase A). A new inhibitor is described, 5'-diphosphoadenosine 3'-phosphate, which binds to RNase A more tightly than any previous low molecular weight compound: its Ki value of 1.3 microM at pH 7 is 8-fold lower than that for uridine-vanadate, a transition-state analog, and 110-fold lower than that for 2'-CMP, one of the best-characterized RNase A ligands. The new inhibitor is found to contact RNase A residues that are conserved in several homologous mammalian RNases and hence should be able to serve as a basis for the design of even tighter-binding inhibitors of these enzymes.
作为开发对那些能诱导生物学反应的胰腺核糖核酸酶超家族成员具有稳定性、选择性和强效性抑制剂的第一步,我们聚焦于低分子量化合物,并研究了它们与牛胰腺核糖核酸酶A(RNase A)活性位点的相互作用。描述了一种新的抑制剂,即5'-二磷酸腺苷3'-磷酸,它与RNase A的结合比任何先前的低分子量化合物都更紧密:其在pH 7时的Ki值为1.3 microM,比过渡态类似物尿苷-钒酸盐低8倍,比特征最明确的RNase A配体之一2'-CMP低110倍。发现这种新抑制剂与几种同源哺乳动物核糖核酸酶中保守的RNase A残基接触,因此应该能够作为设计这些酶更紧密结合抑制剂的基础。